As of 1:07pm ET
| -0.0012 / -0.40%|
The 2 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 1.75, with a high estimate of 2.00 and a low estimate of 1.50. The median estimate represents a +478.90% increase from the last price of 0.30.
The current consensus among 2 polled investment analysts is to Buy stock in NovaBay Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.